Over-the-counter (“OTC”) derivatives are key elements in many of our financial markets. The Dodd-Frank Act and other regulations have changed and are continuing to change how these important instruments are regulated and transacted. This program will introduce the instruments and their current environment.
A derivative is a financial instrument that allocates the risks and price exposures associated with a designated reference asset or entity between the parties thereto. Derivatives can provide price exposure or price insulation to changes in the price or level of an open-ended range of assets or baskets of assets, including indices, stocks, interest rates, currencies, bonds, commodities, insured risks, credit risks, investment funds, property, the weather and more. Derivatives are used in an infinite variety of ways by commercial, charitable, educational and governmental entities to manage the commercial and financial risks they confront. OTC derivatives have been bilaterally traded for many years. They are now becoming subject, in some cases, to required clearing and exchange-type trading. An understanding of the current regulations and of the characteristics, documentation and regulation of these instruments is the first step to effective lawyering.
At this program hosted by PLI, experts will explain what OTC derivatives have been, what they are becoming and how they are documented. Panelists will also provide an overview of the regulatory framework for OTC derivatives and OTC derivatives market participants and explain how the regulatory framework is affecting these markets and market participants.
Mayer Brown partner, Curtis Doty, will participate on the panel, “The Regulatory Fundamentals of Swaps,” which will provide an overview of the federal regulation of swaps in the United States.
Visit the event webpage to learn more.
A derivative is a financial instrument that allocates the risks and price exposures associated with a designated reference asset or entity between the parties thereto. Derivatives can provide price exposure or price insulation to changes in the price or level of an open-ended range of assets or baskets of assets, including indices, stocks, interest rates, currencies, bonds, commodities, insured risks, credit risks, investment funds, property, the weather and more. Derivatives are used in an infinite variety of ways by commercial, charitable, educational and governmental entities to manage the commercial and financial risks they confront. OTC derivatives have been bilaterally traded for many years. They are now becoming subject, in some cases, to required clearing and exchange-type trading. An understanding of the current regulations and of the characteristics, documentation and regulation of these instruments is the first step to effective lawyering.
At this program hosted by PLI, experts will explain what OTC derivatives have been, what they are becoming and how they are documented. Panelists will also provide an overview of the regulatory framework for OTC derivatives and OTC derivatives market participants and explain how the regulatory framework is affecting these markets and market participants.
Mayer Brown partner, Curtis Doty, will participate on the panel, “The Regulatory Fundamentals of Swaps,” which will provide an overview of the federal regulation of swaps in the United States.
Visit the event webpage to learn more.
Stay Up To Date With Our Insights
See how we use a multidisciplinary, integrated approach to meet our clients' needs.
Subscribe